SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-01-501031
Filing Date
2001-06-04
Accepted
2001-06-04 00:00:00
Documents
5
Period of Report
2001-05-24
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f73183e8-k.htm 8-K 8280
2 EXHIBIT 10.1 f73183ex10-1.txt EX-10.1 79224
3 EXHIBIT 10.2 f73183ex10-2.txt EX-10.2 51319
4 EXHIBIT 10.3 f73183ex10-3.txt EX-10.3 38329
5 EXHIBIT 99.1 f73183ex99-1.txt EX-99.1 3943
  Complete submission text file 0000891618-01-501031.txt   183026
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 1653886
SIC: 2833 Medicinal Chemicals & Botanical Products